公开(公告)号：US20110027376A1

公开(公告)日：2011-02-03

申请号：US12747639

申请日：2008-12-02

申请人： Yin Chiang Freddy Boey ,  Jan Ma ,  Zheng Wang

发明人： Yin Chiang Freddy Boey ,  Jan Ma ,  Zheng Wang

IPC分类号： A61K9/14 ,  A61K33/00 ,  A61K39/00 ,  A61K38/02 ,  A61P25/16 ,  A61P25/28 ,  A61P25/00 ,  A61P3/04 ,  A61P9/00 ,  A61P3/00 ,  A61P3/10 ,  A61P35/00 ,  A61P37/06 ,  A61P9/12 ,  A61P27/02

CPC分类号： A61K9/5031 ,  A61K9/107 ,  A61K9/19 ,  B01J13/06 ,  B01J13/22

摘要： The present invention refers to a method of synthesizing a multi-walled microsphere comprising at least one hydrophilic active compound as well as to a multi-walled microsphere obtained by the method of the present invention. The present invention further refers pharmaceutical compositions including multi-walled microspheres of the present invention.

摘要翻译： 本发明涉及一种合成包含至少一种亲水性活性化合物的多壁微球体以及通过本发明的方法获得的多壁微球体的方法。 本发明还涉及包含本发明多壁微球的药物组合物。

公开(公告)号：US20090017787A1

公开(公告)日：2009-01-15

申请号：US11571234

申请日：2006-06-23

申请人： Zheng Wang

发明人： Zheng Wang

IPC分类号： H04M15/00

CPC分类号： H04M15/14 ,  H04M15/00 ,  H04M15/80 ,  H04M15/8011 ,  H04M15/8355 ,  H04M2215/2093 ,  H04M2215/74 ,  H04M2215/7407 ,  H04M2215/8116

摘要： The invention discloses a charging method in PoC service so as to solve the problem that a Push to talk over Cellular (PoC) user's speech priority setting is not limitation and thereby causes the priority policy loses its speech scheduling capability in the prior art. The method disclosed in the present invention includes the following processes: after a speech of a user is completed, the PoC server logs charging information and a speech priority of the user, and uploads the charging information and the speech priority to a charging system; the charging system charges the user in accordance with the charging information and a charging rate corresponding to the speech priority.

摘要翻译： 本发明公开了一种PoC业务中的计费方式，解决了一键通话（PoC）用户语音优先级设置不受限制，从而导致优先级策略在现有技术中失去其语音调度能力的问题。 本发明公开的方法包括以下处理：在用户的语音完成之后，PoC服务器记录用户的计费信息和语音优先级，并将计费信息和语音优先级上传到计费系统; 充电系统根据充电信息和对应于语音优先级的充电速率对用户收费。

公开(公告)号：US20070076601A1

公开(公告)日：2007-04-05

申请号：US11454833

申请日：2006-06-19

申请人： Yufei Wang ,  Zheng Wang ,  Leah Zhang

发明人： Yufei Wang ,  Zheng Wang ,  Leah Zhang

IPC分类号： H04L12/26

CPC分类号： H04L43/0882 ,  H04L41/083 ,  H04L41/5003 ,  H04L41/5025 ,  H04L45/00 ,  H04L45/12 ,  H04L45/123 ,  H04L45/50

摘要： Traffic demands are routed across links of an information network so as to avoid congestion and allow for future traffic growth. Traffic demands from a source node to a destination node of the network are monitored, including bandwidths associated with each of the demands. For each demand, and for a given link of the network, that portion of the bandwidth associated with each traffic demand which is provided by the given link, is determined. A maximum value of link utilization among all links of the network is then determined, wherein link utilization is defined as the amount of bandwidth used by all traffic demands routed through a given link with respect to a total capacity of the link. Traffic demands are then routed across the links of the network in such a manner as to minimize the maximum value of link utilization.

摘要翻译： 交通需求通过信息网络的链路进行路由，以避免拥塞并允许将来流量增长。 监视从源节点到网络的目的地节点的业务需求，包括与每个需求相关联的带宽。 对于每个需求，并且对于网络的给定链路，确定与由给定链路提供的每个业务需求相关联的带宽的那部分。 然后确定网络的所有链路之间的链路利用率的最大值，其中链路利用率被定义为相对于链路的总容量通过给定链路路由的所有业务需求所使用的带宽量。 然后，以使得链路利用率的最大值最小化的方式将网络的链路路由到业务需求。

公开(公告)号：US07102323B2

公开(公告)日：2006-09-05

申请号：US11274499

申请日：2005-11-16

申请人： George Zhou ,  Jack Ma ,  Zheng Wang

发明人： George Zhou ,  Jack Ma ,  Zheng Wang

IPC分类号： H02P27/04

CPC分类号： H02P6/181 ,  H02P6/182 ,  H02P25/024 ,  H02P27/02

摘要： A method and an apparatus optimize performance of a motor drive system. The method according to one embodiment comprises: selecting a property for a rated operation point; selecting inverter system characteristics and motor characteristics such that a motor drive system including an inverter system having the selected inverter system characteristics operatively connected to a motor having the selected motor characteristics will have a rated operation point exhibiting the property; providing an inverter system having the selected inverter system characteristics; operatively connecting a motor having the selected motor characteristics to the inverter system; and minimizing current of the motor drive system including the motor operatively connected to the inverter system in entire operating range of the motor drive system.

摘要翻译： 一种方法和装置优化电动机驱动系统的性能。 根据一个实施例的方法包括：为额定操作点选择属性; 选择变频器系统特性和电动机特性，使得包括具有选择的逆变器系统特性的变频器系统特性的电动机驱动系统可操作地连接到具有选择的电动机特性的电动机，具有显示该特性的额定运行点; 提供具有所选择的逆变器系统特性的逆变器系统; 将具有所选电动机特性的电动机可操作地连接到逆变器系统; 并且在电动机驱动系统的整个工作范围内使电动机驱动系统的电流最小化，包括可操作地连接到逆变器系统的电动机。

公开(公告)号：US20060189619A1

公开(公告)日：2006-08-24

申请号：US11362468

申请日：2006-02-24

申请人： Abdolsamad Tadayon ,  Jacqueline Lunetta ,  Kiomars Karami ,  Zheng Wang

发明人： Abdolsamad Tadayon ,  Jacqueline Lunetta ,  Kiomars Karami ,  Zheng Wang

IPC分类号： A61K31/498 ,  C07D487/02

CPC分类号： C07D471/04

摘要： The present invention relates to Gonadotropin Releasing Hormone (“GnRH”) (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists.

摘要翻译： 本发明涉及促性腺激素释放激素（“GnRH”）（也称为激素释放激素）受体拮抗剂。

公开(公告)号：US06353126B1

公开(公告)日：2002-03-05

申请号：US09345304

申请日：1999-06-30

申请人： Chitoor S. Subramaniam ,  Zheng Wang

发明人： Chitoor S. Subramaniam ,  Zheng Wang

IPC分类号： C07C25314

CPC分类号： C07C253/20 ,  C07C255/09

摘要： An improved process for the commercial production of malononitrile by the dehydration of cyanoacetamide employs cyanuric chloride in the presence of a catalytic amount of N,N-dimethylformamide and in a polar solvent that is removed by vacuum distillation at a temperature below 100° C. The N,N-dimethylformamide is added in a molar ratio of 0.16 moles for each mole of cyanoacetamide present in the starting solution.

摘要翻译： 通过氰基乙酰胺脱水生产丙二腈的改进方法是在催化量的N，N-二甲基甲酰胺存在下，并在极性溶剂中使用氰尿酰氯，该极性溶剂在低于100℃的温度下通过真空蒸馏除去。 以每摩尔存在于起始溶液中的氰基乙酰胺的摩尔比为0.16摩尔加入N，N-二甲基甲酰胺。

公开(公告)号：US06235944B1

公开(公告)日：2001-05-22

申请号：US09234572

申请日：1999-01-21

申请人： Thomas V. John ,  Chitoor S. Subramaniam ,  Zheng Wang ,  Richard J. Kucera, Jr.

发明人： Thomas V. John ,  Chitoor S. Subramaniam ,  Zheng Wang ,  Richard J. Kucera, Jr.

IPC分类号： C07C4128

CPC分类号： C07C41/01 ,  C07C2601/10 ,  C07C2601/16 ,  C07C43/188 ,  C07C43/16

摘要： The present invention relates to a general synthesis for producing secondaryalkoxy-1-alkenes in commercial quantities in good yields by reacting cyclic and acyclic ketones and the corresponding alcohol with a secondary alkyl orthoformate ester in the presence of an acid catalyst, a Lewis acid, ferric chloride being preferred, and recovering the produce as a liquid of high purity.

摘要翻译： 本发明涉及通过在酸催化剂，路易斯酸，三价铁的存在下使环状和无环酮与相应的醇与原烷基甲酸仲烷基酯反应，以良好的产率生产二烷氧基-1-烯烃的一般合成方法 优选氯化物，并回收作为高纯度液体的产物。

公开(公告)号：US10025123B1

公开(公告)日：2018-07-17

申请号：US14969906

申请日：2015-12-15

申请人： National Technology & Engineering Solutions of Sandia, LLC ,  Wenjun Qiu ,  Zheng Wang

发明人： Peter Thomas Rakich ,  Heedeuk Shin ,  Ryan Camacho ,  Jonathan Albert Cox ,  Robert L. Jarecki, Jr. ,  Wenjun Qiu ,  Zheng Wang

IPC分类号： G02F1/01 ,  G02F1/125

摘要： The various technologies presented herein relate to various hybrid phononic-photonic waveguide structures that can exhibit nonlinear behavior associated with traveling-wave forward stimulated Brillouin scattering (forward-SBS). The various structures can simultaneously guide photons and phonons in a suspended membrane. By utilizing a suspended membrane, a substrate pathway can be eliminated for loss of phonons that suppresses SBS in conventional silicon-on-insulator (SOI) waveguides. Consequently, forward-SBS nonlinear susceptibilities are achievable at about 3000 times greater than achievable with a conventional waveguide system. Owing to the strong phonon-photon coupling achievable with the various embodiments, potential application for the various embodiments presented herein cover a range of radiofrequency (RF) and photonic signal processing applications. Further, the various embodiments presented herein are applicable to applications operating over a wide bandwidth, e.g. 100 MHz to 50 GHz or more.

公开(公告)号：US09299643B2

公开(公告)日：2016-03-29

申请号：US12286149

申请日：2008-09-29

申请人： Zheng Wang ,  Connie Wang ,  Erik Wilson ,  Wen Yu ,  Robert Chiu

发明人： Zheng Wang ,  Connie Wang ,  Erik Wilson ,  Wen Yu ,  Robert Chiu

IPC分类号： H01L29/40 ,  H01L23/485 ,  H01L21/768 ,  H01L23/532 ,  H01L27/105 ,  H01L27/115

CPC分类号： H01L23/485 ,  H01L21/76877 ,  H01L23/53252 ,  H01L27/105 ,  H01L27/1052 ,  H01L27/115 ,  H01L27/11517 ,  H01L2924/0002 ,  H01L2924/00

摘要： An electrically conductive interconnect is provided through an opening in a dielectric layer, electrically connecting two conductive layers. In one embodiment, the interconnect is formed by ruthenium entirely filling the opening in the dielectric layer. In another embodiment, an adhesion layer of titanium is provided in the opening prior to providing the ruthenium. In using this approach, an aspect ratio (i.e., the ratio of the length of the interconnect to the width thereof) of 20:1 or greater is achievable.

摘要翻译： 导电互连通过介电层中的开口设置，电连接两个导电层。 在一个实施例中，互连由完全填充介电层中的开口的钌形成。 在另一个实施方案中，在提供钌之前，在开口中提供钛的粘附层。 在使用这种方法时，可实现20:1或更大的纵横比（互连长度与其宽度之比）。

公开(公告)号：US09095599B2

公开(公告)日：2015-08-04

申请号：US13978272

申请日：2011-12-30

申请人： Junbiao Chang ,  Zheng Wang ,  Suping Zhou

发明人： Junbiao Chang ,  Zheng Wang ,  Suping Zhou

IPC分类号： A61K31/7076 ,  A61K31/706 ,  A61K31/7068 ,  A61K31/7072 ,  A61K45/06 ,  C07H19/10 ,  C07H19/20 ,  C07H19/12 ,  A61K31/075 ,  C07F9/6558 ,  C07F9/6561

CPC分类号： A61K31/706 ,  A61K31/075 ,  A61K31/7068 ,  A61K31/7072 ,  A61K31/7076 ,  A61K45/06 ,  C07F9/65583 ,  C07F9/65616 ,  C07H19/10 ,  C07H19/12 ,  C07H19/20

摘要： This application discloses novel phosphoramidate and phosphonoamidate prodrugs of nucleosides, nucleotides, C-nucleosides, C-nucleotides, phosphonates, and other alcohol-containing drugs; use of these prodrugs for treatment of infectious diseases and cancers, in particular, liver infections and cancers; and methods of preparing these novel phosphoramidate and phosphonoamidate prodrugs.

摘要翻译： 本申请公开了核苷，核苷酸，C-核苷，C-核苷酸，膦酸酯和其它含醇药物的新型氨基磷酸酯和膦酰胺酸酯前药。 使用这些前药用于治疗感染性疾病和癌症，特别是肝脏感染和癌症; 以及制备这些新型氨基磷酸酯和膦酰胺酸酯前药的方法。